Skip to main content

Table 2 Imaging characteristics of patients with myocardial amyloidosis

From: 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

 

Patient 1

Patient 2

Patient 5a

Patient 7

Patient 9

Echocardiography

Moderate concentric LVH with echo-texture suspicious for amyloid

Moderate concentric LVH

Moderate concentric LVH

Moderate concentric LVH with echo-texture suspicious for amyloid

Moderate LVH with echo-texture suspicious for amyloid

Cardiac MRI

N/A

BH with extensive sub-endocardial delayed enhancement consistent with CA

N/A

N/A

N/A

18F-florbetaben PET/MRI

Elevated early and delayed uptake in LV

Elevated early and delayed uptake in LV

Elevated early and delayed uptake in LV

Elevated early and delayed uptake in LV

Elevated early and delayed uptake in LV

  1. LVH left ventricular hypertrophy, BH biventricular hypertrophy, CA cardiac amyloidosis, LV left ventricle, N/A not available
  2. aMyocardial involvement was proven by biopsy